Form 4: Ceribell Senior VP Executes Options, Sells Shares

Ceribell's Senior VP of Finance and PAO, David Foehr, executed stock options and subsequently sold a portion of the acquired shares under a pre-arranged 10b5-1 trading plan.

Summary

• David Foehr, Senior VP, Finance and PAO of Ceribell, Inc., reported several transactions involving the company's common stock.
• On November 20, 2025, Foehr disposed of 484 shares of common stock at a price of $13.64 per share, likely for tax withholding purposes, leaving 18,900 shares beneficially owned.
• On January 5, 2026, Foehr exercised stock options to acquire 3,403 shares of common stock at an exercise price of $4.70 per share, increasing beneficial ownership to 22,303 shares.
• Immediately following the exercise on January 5, 2026, Foehr sold 3,403 shares of common stock at a price of $22.60 per share, returning beneficial ownership to 18,900 shares.
• Also on January 5, 2026, Foehr exercised additional stock options to acquire 2,153 shares of common stock at an exercise price of $4.70 per share, bringing beneficial ownership to 21,053 shares.
• Concurrently, Foehr sold 2,153 shares of common stock at a price of $22.60 per share, again returning beneficial ownership to 18,900 shares.
• All sales reported on January 5, 2026, were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
• Following these transactions, Foehr beneficially owns 18,900 shares of common stock directly and holds 63,001 unexercised stock options.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The transactions are routine insider equity management, including option exercises and sales under a pre-arranged 10b5-1 plan, which mitigates any negative interpretation of the sales.

Positives

• The executive exercised stock options at a significantly lower price ($4.70) than the market price at which shares were sold ($22.60), indicating a substantial personal gain from long-term equity incentives.
• The transactions were conducted under a Rule 10b5-1 trading plan, which suggests a pre-planned and systematic approach to managing equity, reducing concerns about opportunistic insider trading.

Negatives

• The sale of shares by a senior executive, even under a 10b5-1 plan, reduces their direct equity stake in the company, which some investors might interpret as a slight reduction in insider alignment.

Risks

• While the sales were pre-planned, any significant insider selling can sometimes be perceived by the market as a potential signal, which could lead to short-term negative sentiment or scrutiny regarding the company's future prospects.

Future Outlook

The filing does not provide specific forward-looking statements or guidance regarding the company's performance or strategic direction. It primarily reports past insider transactions.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions and does not provide information directly related to broader industry trends or competitive landscape. It reflects an individual executive's equity management activities.

Stakeholder Impact

• Shareholders may observe the executive's decision to realize value from options and sell shares, which could be interpreted as a normal part of executive compensation and financial planning, especially given the 10b5-1 plan.
• The transactions demonstrate the executive's personal financial activity related to their compensation structure.

Next Steps

• The remaining shares subject to the stock option will continue to vest in 36 successive, equal monthly installments after May 31, 2023, contingent on the reporting person's continued employment or service relationship with Ceribell, Inc.

Key Dates

Recommendation

The filing details routine insider transactions, specifically the exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 trading plan. While insider selling can sometimes be a concern, the pre-planned nature of these sales reduces the likelihood of them signaling a negative outlook on the company's future. There is no new fundamental information about Ceribell's operations or financial health that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting further operational or financial updates.

Keywords

Ceribell, CBLL, Form 4, Insider Trading, Stock Options, 10b5-1 Plan, Executive Compensation, Equity Sales, David Foehr